Iovance Biotherapeutics: Barclays raises target price to $19 from $18
IOVA•Barclays raised its target price for Iovance Biotherapeutics to $19 from $18.
Related News
Paylocity target price raised to $176 from $162
PCTY•
Nasdaq trade halt continues, reason not available at 03:58 a.m.
NEXRW•
Nasdaq trade halt continues, reason not available at 3:58 a.m.
AIIOW•
Nasdaq trade halt continues; reason not available at 03:58 am
HCHL•
Tesla to wind down Cybertruck production at Texas factory as it struggles to win appeal
TSLA•